TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Bio-Gene Technology Ltd. ( (AU:BGT) ) has provided an announcement.
Bio-Gene Technology Limited announced a change in the director’s interest, with Andrew Guthrie acquiring 217,392 ordinary shares and 217,392 unlisted options through a placement approved by shareholders. This change reflects the company’s ongoing efforts to strengthen its financial position and enhance shareholder value, potentially impacting its market presence and stakeholder confidence.
More about Bio-Gene Technology Ltd.
Bio-Gene Technology Limited operates in the biotechnology industry, focusing on the development of insecticide products. The company aims to address the increasing demand for effective pest control solutions in agriculture and public health sectors.
Average Trading Volume: 249,678
Technical Sentiment Signal: Sell
Current Market Cap: A$4.8M
Learn more about BGT stock on TipRanks’ Stock Analysis page.